Skip to content

Impact and function of the mitochondria transcription factor A (TFAM) in sepsis

Impact and function of the mitochondria transcription factor A (TFAM) in sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015619
Enrollment
30
Registered
2018-10-08
Start date
2018-10-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers A41.9

Interventions

Group 1: Full blood is collected from 20 healthy volunteers. Peripheral mononuclear blood cells (PMBCs) are examined for mitochondrial dysfunction after LPS stimulation during the time courses (after

Sponsors

Universitätsklinikum Knappschaftskrankenhaus Bochum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: voluntary; healthy individuals age >18, <65, no risk for blood drawing

Exclusion criteria

Exclusion criteria: low body weight (65, anemia, anamnestic incompatibility of blood drawing

Design outcomes

Primary

MeasureTime frame
Evaluation of the ratio of the mitochondrial and cytosolic concentration of TFAM beofre LPS stimulation and after LPS stimualtion during the time course (after 1/2, 4, 24, 48 hours) by western blot.

Secondary

MeasureTime frame
Evalutaion of the expression of mitochondrial mRNA, mRNA of TFAM and the regulation proteins (NFkB, PGC-1a, NRF1, NRF2) during the time course (after 1/2, 4, 24, 48 hours) by RT-PCR and Elisa. Furthermore the different TFAM Expression and distribution will be observerd in surivors compared to non-survivors after 30 days.

Countries

Germany

Contacts

Public ContactTim Rahmel

Universitätsklinikum Knappschaftkrankenhaus Bochum GmbH Klinik fürAnästhesiologie, Intensivmedizin und Schmerztherapie

Tim.Rahmel at kk-bochum.de00492342993001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026